Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised

Sobreira, Emmanuelle; Pena-Pereira, Márcio A.; Eckeli, Alan L.; Sobreira-Neto, Manoel A.; Chagas, Marcos H. N.; Foss, Maria P.; Cholerton, Brenna; Zabetian, Cyrus P.; Mata, Ignacio F.; Tumas, Vitor.
Arq. neuropsiquiatr ; 73(11): 929-933, Nov. 2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-762884

Documentos relacionados

  1. Meaningful cognitive change for the Minimal Assessment of Cognitive Function in Multiple Sclerosis.
  2. The Everyday Compensation (EComp) Questionnaire: Construct Validity and Associations with Diagnosis and Longitudinal Change in Cognition and Everyday Function in Older Adults.
  3. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
  4. The weekly calendar planning activity in multiple sclerosis: A top-down assessment of executive functions.
  5. The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
  6. Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe.
  7. Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease.
  8. Predictors of Cognitive Change in Parkinson Disease: A 2-year Follow-up Study.
  9. [Diagnosis and therapy for neurocognitive disorders in Parkinson's disease].
  10. Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised.